GDTC logo

CytoMed Therapeutics Limited (GDTC) Operating Expenses

Annual Operating Expenses

$2.86 M
+$1.51 M+112.37%

31 December 2023

GDTC Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GDTC Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+112.4%-
3 y3 years+214.0%-
5 y5 years--

GDTC Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+214.0%
5 y5 yearsat high+214.0%
alltimeall timeat high+214.0%

CytoMed Therapeutics Limited Operating Expenses History

DateAnnualQuarterly
Dec 2023
$2.86 M(+112.4%)
-
Dec 2022
$1.35 M(+4.8%)
-
DateAnnualQuarterly
Dec 2021
$1.29 M(+41.1%)
-
Dec 2020
$911.10 K
-

FAQ

  • What is CytoMed Therapeutics Limited annual total operating expenses?
  • What is the all time high annual operating expenses for CytoMed Therapeutics Limited?
  • What is CytoMed Therapeutics Limited annual operating expenses year-on-year change?

What is CytoMed Therapeutics Limited annual total operating expenses?

The current annual operating expenses of GDTC is $2.86 M

What is the all time high annual operating expenses for CytoMed Therapeutics Limited?

CytoMed Therapeutics Limited all-time high annual total operating expenses is $2.86 M

What is CytoMed Therapeutics Limited annual operating expenses year-on-year change?

Over the past year, GDTC annual total operating expenses has changed by +$1.51 M (+112.37%)